Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 329047

1.

[The genetic factors of non-response to anti-vascular endothelial growth factor therapy].

Xu SX, Huang SW, Su GF.

Zhonghua Yan Ke Za Zhi. 2018 Nov 11;54(11):873-878. doi: 10.3760/cma.j.issn.0412-4081.2018.11.016. Chinese.

PMID:
30440160
2.

Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.

Park CH, Lee AR, Lee YR, Eun CS, Lee SK, Han DS.

Helicobacter. 2018 Nov 15:e12547. doi: 10.1111/hel.12547. [Epub ahead of print]

PMID:
30440093
3.

Clathrin adaptor GGA1 modulates myogenesis of C2C12 myoblasts.

Isobe M, Lee S, Waguri S, Kametaka S.

PLoS One. 2018 Nov 15;13(11):e0207533. doi: 10.1371/journal.pone.0207533. eCollection 2018.

PMID:
30440034
4.

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system.

Galibert L, Savy A, Dickx Y, Bonnin D, Bertin B, Mushimiyimana I, van Oers MM, Merten OW.

PLoS One. 2018 Nov 15;13(11):e0207414. doi: 10.1371/journal.pone.0207414. eCollection 2018.

PMID:
30440025
5.

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.

Lee JJA, Maruyama R, Duddy W, Sakurai H, Yokota T.

Mol Ther Nucleic Acids. 2018 Oct 11;13:596-604. doi: 10.1016/j.omtn.2018.10.004. [Epub ahead of print]

PMID:
30439648
6.

Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer.

Xiong D, Wang Y, Singavi AK, Mackinnon AC, George B, You M.

iScience. 2018 Oct 25;9:258-277. doi: 10.1016/j.isci.2018.10.021. [Epub ahead of print]

PMID:
30439581
7.

Efficiency of dual siRNA mediated gene therapy for intervertebral disc degeneration (IVDD).

Rajkiran Reddy B, Satish Kumar V, Ghulam Hassan D, Vijayanand P, Murahari P, Surekha MV, Gurava Reddy AV, Madhusudhana Rao N, Subbaiah G.

Spine J. 2018 Nov 12. pii: S1529-9430(18)31173-2. doi: 10.1016/j.spinee.2018.10.016. [Epub ahead of print]

PMID:
30439528
8.

Targeting epigenetics and non-coding RNAs in atherosclerosis: From mechanisms to therapeutics.

Xu S, Kamato D, Little PJ, Nakagawa S, Pelisek J, Jin ZG.

Pharmacol Ther. 2018 Nov 12. pii: S0163-7258(18)30200-6. doi: 10.1016/j.pharmthera.2018.11.003. [Epub ahead of print] Review.

PMID:
30439455
9.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy.

Kirchhof MG, Landells I, Lynde CW, Gooderham MJ, Hong CH.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):6S-9S. doi: 10.1177/1203475418803626.

PMID:
30439299
10.

Polymorphism in IFNL3/IL28B gene and risk to non-cirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.

Khan AJ, Saraswat VA, Ranjan P, Parmar D, Negi TS, Mohindra S.

J Med Virol. 2018 Nov 15. doi: 10.1002/jmv.25359. [Epub ahead of print]

PMID:
30431653
11.

Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial.

Lim H, Bang CS, Shin WG, Choi JH, Soh JS, Kang HS, Yang YJ, Hong JT, Shin SP, Suk KT, Lee JJ, Baik GH, Kim DJ.

Medicine (Baltimore). 2018 Nov;97(46):e13245. doi: 10.1097/MD.0000000000013245.

PMID:
30431605
12.

Safe childbirth for a type 1 antithrombin-deficient woman with novel mutation in the SERPINC1 gene undergoing antithrombin concentrate therapy.

Ikeda Y, Yamanouchi J, Hato T, Yasukawa M, Takenaka K.

Blood Coagul Fibrinolysis. 2018 Nov 13. doi: 10.1097/MBC.0000000000000785. [Epub ahead of print]

PMID:
30431449
13.

Exosomes as drug carriers for clinical application.

Di C, Zhang Q, Wang Y, Wang F, Chen Y, Gan L, Zhou R, Sun C, Li H, Zhang X, Yang H, Zhang H.

Artif Cells Nanomed Biotechnol. 2018 Nov 15:1-7. doi: 10.1080/21691401.2018.1501381. [Epub ahead of print]

PMID:
30431368
14.

Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells.

Wang JB, Jin Y, Wu P, Liu Y, Zhao WJ, Chen JF, De W, Yang F.

Oncol Rep. 2018 Nov 12. doi: 10.3892/or.2018.6866. [Epub ahead of print]

PMID:
30431129
15.

Evironmental pollutant perfluorodecanoic acid upregulates cIAP2 to suppress gastric cell senescence.

Zhang Z, Song N, Peng Y, Fan Z, Han M, Zhao M, Dong T, Liu S.

Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6856. [Epub ahead of print]

PMID:
30431128
16.

TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways.

Ye J, Chu C, Chen M, Shi Z, Gan S, Qu F, Pan X, Yang Q, Tian Y, Wang L, Yang W, Cui X.

Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6854. [Epub ahead of print]

PMID:
30431120
17.

Controlling HCV infection by targeting its translation initiation site in PBMCs using siRNA; In Vitro.

Youssef SS, Elemeery MN, Eldein SS, Ghareeb DA.

Infect Disord Drug Targets. 2018 Nov 14. doi: 10.2174/1871526518666181114164254. [Epub ahead of print]

PMID:
30430948
18.

The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy.

Liu N, Zhao R, Ma Y, Wang D, Yan C, Zhou D, Yin F, Li Z.

Curr Top Med Chem. 2018 Nov 14. doi: 10.2174/1568026618666181115092623. [Epub ahead of print]

PMID:
30430946
19.

Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primates.

Thompson HL, Smithey MJ, Uhrlaub JL, Jeftić I, Jergović M, White SE, Currier N, Lang AM, Okoye A, Park B, Picker LJ, Surh CD, Nikolich-Žugich J.

Aging Cell. 2018 Nov 14:e12865. doi: 10.1111/acel.12865. [Epub ahead of print]

PMID:
30430748
20.

Target therapy for metastatic breast cancer.

Rachdi H, Mokrani A, Batti R, Ayadi M, Chraiet N, Mezlini A.

Tunis Med. 2018 Aug - Sep;96(8-09):465-471.

PMID:
30430522

Supplemental Content

Loading ...
Support Center